Hasan Serkan DOGAN
Hacettepe University, Faculty of Medicine, Department of Urology and Division of Pediatric Urology, Ankara, Turkey
He completed his medical education in 1998 at Hacettepe University Faculty of Medicine (English) and started his residency in the urology department of the same university. He worked as a pediatric urology fellow for two years after 2003 in the same clinic. Since 2006, he worked in the urology departmentand pediatric urology division in Uludag University faculty of Medicine. He has been certificated as 'Fellow of European Academy of Pediatric Urology' in 2008. He had the title of associate professor in 2010 and had the right of being 'Specialist of Pediatric Urology' which was approved by Ministry of Health. He had the international experience of pediatric urology by visiting the Innsbruck University (Austria) and Aarhus University (Denmark) in 2011. By 2012, he is the academic member of Hacettepe University Faculty of Medicine Department of Urology and Division of Pediatric Urology. He became the professor of urology in 2015. He served as a board member of Turkish Society of Pediatric Urology and is the present president of Society of Urologic Surgery in Turkey. He is the active member of Pediatric Urology Guidelines Panel under European Association of Urology. His areas of interest are diagnosis, medical and surgical (open, laparoscopic, endourologic) management of acquired or congenital urologic abnormalitieis of the pediatric age group, renal transplantation and endoscopic stone surgery. He has more than 110 international articles and personal H-index is 17 (web of science database).
Prof. Dr Serdar Tekgul FEAPU
Professor and Chair, Department of Urology, Hacettepe University, School of Medicine, Ankara TURKEY
Dr. Serdar Tekgul is Professor of Urology at Hacettepe University in Ankara. Following his urology training at Hacettepe University, he has had his Pediatric Urology fellowship training at University of Washington, Children’s Hospital with Dr. Michael Mitchell in 1994-95. Since then he has limited all of his academic and clinical work to Pediatric Urology. Since 2003, he has been chairing the section of Pediatric Urology at Hacettepe University which is one of the accredited training programs for pediatric urology in Europe. He is currently the head of the Department of Urology at Hacettepe. Hacettepe University, Department of Urology is the leading urology department in the country based on several objective criteria. His academic interests in different areas of pediatric urology are obstructive uropathy, voiding dysfunction, reflux, and reconstructive surgery of the bladder and childhood urolithiasis. He is actively involved in the administrative work for urology residency training programs. He has chaired the Turkish Board of Urology, Exam Committee 2002-2009. He has been the president of Turkish Pediatric Urology Association in 2007-2011. He acted as the President of Society of Urological Surgery in Turkey within 2010-2013. He has more than 100 publications in peer view journals (his H index is 22 (WOS) and has more than 3500 citations). He has made many presentations and he has been invited as lecturer in numerous International meetings for Pediatric Urology and has been visiting Professor in several pediatric urology centers around the world. He is a member of both Pediatric Urology Societies in Europe and in U.S. He is a member of Society of Pediatric Urological Surgeons (SPUS). He is a member of American Association of Genito-Urinary Surgeons (AAGUS).
He has been the organizer of several ESPU courses, 9th biannual ICCS meeting and 21st ESPU annual meeting. He has been one of the assistant editors of Journal of Pediatric Urology. He is in the editorial board of several international journals for urology and Pediatric Urology. He has been a member of the Children’s Committee for the International Consultation for Incontinence (ICI) in 2004 and 2008. He was the committee chair in 2008 in Paris. He is a member of the EAU guidelines committee and chairing the Pediatric Urology group since 2008. He is a faculty member of European School of Urology and has been lecturer in several ESU courses and annual EUREP course. He has been a board member of European Society for Pediatric Urology (ESPU) and has acted as the Chairman of Educational Committee for 6 years and the Scientific Secretary of ESPU the for 2 years. He served as the Secretary of ESPU between 2010 and 2016. He is currently a member of European Board of Urology (EBU)executive committee and chairman of the EBU examination committee. He has recently been elected as the next President of European Society for Pediatric Urology
John Sfakianos
Assistant Professor at the Icahn School of Medicine at Mount Sinai, USA
Dr. Sfakianos is an Assistant Professor at the Icahn School of Medicine at Mount Sinai. He completed his MD from the School of Medicine and Biosciences at Buffalo and completed his internship and residency at the State University of New York at Downstate Medical Center. He then went on to fellowship in Urologic Oncology, which was completed at Memorial Sloan-Kettering Cancer Center. His clinical and research focus is on understanding and treating patients with urothelial carcinoma. He has lead the efforts in improving robotic cystectomy techniques, more specifically by performing this surgery without the use of opioids, Non-opioid Protocol (NOP) and completely minimally invasive with intra-corporeal robotic techniques.
He is focused on translational research working with both human tissue and murine models to help understand and identify novel targets in treating urothelial carcinoma. He studies both the molecular biology underlying urothelial carcinoma as well as the immune microenvironment. Specifically his focus is on identifying novel targets for BCG resistant non-muscle invasive bladder cancer. He is the partnering PI on a DOD team translational grant and co-investigator on sever RO1 NIH grants studying the immune mechanisms in both non-muscle and muscle invasive bladder cancer. Dr. Sfakianos is the author of over 125 articles in peer-reviewed publications and several book chapters on urothelial carcinoma.
He is focused on translational research working with both human tissue and murine models to help understand and identify novel targets in treating urothelial carcinoma. He studies both the molecular biology underlying urothelial carcinoma as well as the immune microenvironment. Specifically his focus is on identifying novel targets for BCG resistant non-muscle invasive bladder cancer. He is the partnering PI on a DOD team translational grant and co-investigator on sever RO1 NIH grants studying the immune mechanisms in both non-muscle and muscle invasive bladder cancer. Dr. Sfakianos is the author of over 125 articles in peer-reviewed publications and several book chapters on urothelial carcinoma.